InvestorsHub Logo
icon url

Puffer

05/10/13 11:37 PM

#67918 RE: JG36 #67899

Note the use of the indefinite article. I said "a drug developer", not "Nanoviricides".



ok, so you weren't talking about NNVC. In a conversation about Phase III trial costs for NNVC, your mention of tripling share count applied to everybody but NNVC.


This statement was made in the context of debating the cost of phase III trials for Flucide



Oh wait, I guess you were talking about NNVC.

That is certainly some tortured verbiage... Shall we call it the "indefinite article"?





icon url

Puffer

05/14/13 9:54 AM

#67953 RE: JG36 #67899



JG stated --

I never said that FDA approval was required for doing trials in Australia.




To which I responded --

You have a short memory. You deleted your post after I corrected you.


--------------------------------------------------------------------------------


JG again stated--

I never said that, so you didn't "correct" me, and I never deleted any of my posts.



And here it is, referred to in my post before you could change it -

It will be some period of time after that before the FDA gives IND approval. So, if all goes reasonably well I hope to see phase I trials start early in 2015




http://investorshub.advfn.com/boards/read_msg.aspx?message_id=85000707

Remember what I was saying about credibility?